SPX3,783.28-7.65 -0.20%
DIA302.79-0.35 -0.12%
IXIC11,148.64-27.77 -0.25%

Cantor Fitzgerald Initiates Coverage On DICE Therapeutics with Overweight Rating, Announces Price Target of $36

Cantor Fitzgerald analyst Prakhar Agrawal initiates coverage on DICE Therapeutics (NASDAQ:DICE) with a Overweight rating and announces Price Target of $36.

Benzinga · 09/14/2022 08:38
Cantor Fitzgerald analyst Prakhar Agrawal initiates coverage on DICE Therapeutics (NASDAQ:DICE) with a Overweight rating and announces Price Target of $36.